The U.S. Department of Justice has issued a federal grand jury subpoena to NYU Langone Health, seeking information about minors who received gender-affirming care between 2020 and 2026. The subpoena also requests the names of medical providers involved in such treatments.
Key Takeaways
The U.S. Department of Justice has issued a federal grand jury subpoena to NYU Langone Health seeking information about minors who received gender-affirming care between 2020 and 2026, as part of the Trump administration's broader crackdown on such treatments. The hospital network must notify patients before disclosing protected information under New York state's shield law.
NYU Langone was one of several institutions issued a subpoena by the U.S. Attorney’s Office in the Northern District of Texas on May 7, according to multiple reports. Under New York state's shield law, the hospital network must notify patients and those involved in their care 30 days prior to disclosing protected information.
This latest action is part of the Trump administration's broader crackdown on gender-affirming care for children across the U.S. In January 2025, Donald Trump issued an executive order aimed at curtailing access to such medical care and directed federally funded institutions to end these treatments.
As reported by The Guardian, NYU Langone started canceling gender-affirming care for new trans youth patients shortly after the executive order was issued. The hospital network then ceased its gender-affirming care program for youth in February 2026, citing regulatory challenges and the departure of their medical director.
LGBTQ rights advocates rallied in Manhattan on Wednesday morning, calling on the hospital to ignore the subpoena. Manhattan Borough President Brad Hoylman-Sigal stated, 'It is outrageous that a MAGA-appointed attorney in Texas, under the auspices of the U.S. Department of Justice, is persecuting the parents of trans patients here in New York City.' A spokesperson for New York Attorney General Letitia James emphasized that New York has strong protections in place to protect the privacy of patient records.
Studies have shown that hormonal therapy and puberty blockers can improve mental health outcomes for transgender individuals. A 2022 report revealed that a majority of transgender and non-binary youth who received gender-affirming care reported less self-harm, suicidal ideation, and depression.
How this summary was created
This summary synthesizes reporting from 5 independent publishers using AI. All sources are cited and linked below. NewsBalance is a news aggregator and media literacy tool, not a news publisher. AI-generated content may contain errors or inaccuracies — always verify important information with the original sources.